Clinical Trials
4 trialsNCT01228435 2017-12-04
IPI-504 in NSCLC Patients With ALK Translocations
Massachusetts General Hospital
Phase 2 Terminated
NCT00004065 2013-06-24
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00066326 2013-04-05
Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT00004075 2011-08-03
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
Mayo Clinic
Phase 1 Completed